ASE · Drug Manufacturers - Specialty & Generic

APUS (APUS) Stock

$5.15 +4.67% ASE: APUS Healthcare

Valuation

MetricValue
Price$5.15
Market Cap$7.77M
P/E Ratio-7.51
P/B Ratio0.01
P/S Ratio0.00
EPS (TTM)$0.00
52-Week High$40.31
52-Week Low$0.64
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.92%
ROA-3.66%
ROCE-7.84%
Gross Margin0.00%
Operating Margin0.00%
Net Margin0.00%
Debt/Equity0.08
Current Ratio1.31

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-1.0M$-1.0M$-1.0M$-1.0M$-12.0M
Net Profit$-1.0M$-1.0M$-1.0M$-1.0M$-6.0M
EPS$-0.81$-0.53$-0.61$-1.10$-0.55
Op Margin—————

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$0$0$0$0$164.0M
Total Liabilities$0$1.0M$0$1.0M$11.0M
Cash$0$0$0$0$2.0M
Borrowings$0$1.0M$0$1.0M$8.0M

Latest News

Inside the ICE House x Las Vegas: MindWave Innovations CEO Dr. Vin Menon NYSE · Jul 8, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-1.0M$0$-1.0M$-1.0M$-9.0M
Investing Cash Flow$0$0$0$0$-10.0M
Financing Cash Flow$0$0$0$0$0
Net Cash Flow$0$0$0$0$10.0M
Free Cash Flow$-1.0M$0$-1.0M$-1.0M$-9.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-755.40%
Quick Ratio0.90
Interest Coverage—
Return 1Y-96.00%
Return 3Y—
Return 5Y—

Ownership

Insiders Held58.71%
Institutions Held2.97%
Institutions Float Held7.20%
Institutional HolderSharesReport Date
Hemenway Trust Company LLC274,0002026-03-31
Vanguard Capital Management LLC95,9292026-03-31
Geode Capital Management, LLC40,0512026-03-31
Vanguard Fiduciary Trust Co24,0392026-03-31
Two Sigma Securities, LLC10,5502026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About APUS

APUS is led by CEO Vinod Menon, employs 2 people, headquartered in US, publicly traded since 2025.

APUS stock trades at $5.15 with a market capitalization of $7.77M. The stock is valued at a price-to-earnings (P/E) ratio of -7.51, price-to-book of 0.01, price-to-sales of 0.00. Over the past 52 weeks the stock has ranged between $0.64 and $40.31, and currently trades 87.2% below its 52-week high.

On profitability, APUS generates a return on equity (ROE) of -3.92%, return on capital employed of -7.84%, an operating margin of 0.00%, a net profit margin of 0.00%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides